Home
Clinical Trials
Developing a Simple Test to D...

Developing a Simple Test to Diagnose Overactive Bladder

Last Updated: 2022-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In order to develop a test to diagnose overactive bladder from urine, it is essential that this test is at least as accurate as the tools that clinicians currently use. As such, this study will compare the performance of the device in development to the performance of existing methods.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating a Digital Intervention for Overactive Bladder

NCT05170100

Overactive Bladder

COMPLETED NA

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

NCT01367886

Overactive Bladder

COMPLETED NA

A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

NCT01317810

Overactive Bladder (OAB)

WITHDRAWN

Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study

NCT06563193

Overactive Bladder

ENROLLING_BY_INVITATION

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

NCT03807024

Urinary Bladder, Overactive

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overactive Bladder Overactive Bladder Syndrome Detrusor Overactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Urodynamics aka filling cystometry

Participants will be undergoing a routine diagnostic test to characterise bladder function and volume

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The participant is willing and able to give informed consent for participation in the study
* The participant has been diagnosed with over-active bladder
* Aged 18 years or above
* Male or Female

Exclusion Criteria

* The participant is unwilling to give informed consent for participation in the study
* The participant is unable to represent their own interests or is particularly susceptible to coercion (i.e. is deemed as vulnerable)
* The participant has been diagnosed with neurologic disease (stroke, MS, Parkinson's disease, spinal cord injury); history of uterine, cervical, vaginal or urethral cancer; history of cyclophosphamide use or any type of chemical cystitis; history of benign or malignant bladder tumours; has had Botulinum injections, neuromodulation or augmentation cystoplasty
* Aged 17 years or younger.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers